SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001558370-23-005631
Filing Date
2023-04-07
Accepted
2023-04-07 16:32:01
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tmb-20230407xdefa14a.htm DEFA14A 11839
2 GRAPHIC tmb-20230407xdefa14a_bg001.jpg GRAPHIC 240948
3 GRAPHIC tmb-20230407xdefa14a_bg002.jpg GRAPHIC 165937
  Complete submission text file 0001558370-23-005631.txt   573636
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOPHARMA, INC (Filer) CIK: 0001385818 (see all company filings)

IRS No.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEFA14A | Act: 34 | File No.: 001-38247 | Film No.: 23809038
SIC: 2834 Pharmaceutical Preparations